Client News

OKYO Pharma (Nasdaq: OKYO) Announces Closing of $4.0 Million Registered Direct Offering of Ordinary Shares

LONDON and NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”), today announced the closing of its previously announced Company best efforts registered direct offering of 2,666,670 ordinary shares at an offering price […]

Hanryu Holdings’ (NASDAQ:HRYU) FANTOO Application to Host Real-Life Adaptation of Squid Play (Ojingeo Nori) for Prize Pool of Up to USD$1 Million

First-of-its-Kind Squid Play Competition on FANTOO App will Allow Participants from Across the Globe to Compete for Prizes Worth $1 Million, Growing FANTOO User Base and Increasing FANTOO’s Brand Reach SEOUL, SOUTH KOREA / ACCESSWIRE / September 15, 2023 / Hanryu Holdings, Inc. (NASDAQ:HRYU) (the “Company” or “Hanryu”), a media-tech company and creator of FANTOO, an […]

Jiuzi Holdings (NASDAQ: JZXN) Announces Strategic Partnership Agreement to Acquire and Install up to 10,000 Smart Electric Vehicle (EV) chargers by 2027

4-Year-Plan on deployment of the EV chargers in China’s Third and Fourth-Tier Cities for Smart EV chargers, Turning the Green Wheel for Rural Revitalization HANGZHOU, China, Sept. 15, 2023 (GLOBE NEWSWIRE) — Jiuzi Holdings Inc. (NASDAQ: JZXN; the “Company” or “JZXN”), an emerging new energy vehicle (NEV) dealership group operating under the brand name “Jiuzi” […]

Hanryu Holdings (NASDAQ:HRYU) and AISUL Announce Strategic Partnership to Create and Integrate Three-Dimensional, Artificial Intelligence Generated Digital Human into FANTOO Application

SEOUL, SOUTH KOREA / ACCESSWIRE / September 14, 2023 / Hanryu Holdings, Inc. (NASDAQ:HRYU) (the “Company” or “Hanryu”), a media-tech company and creator of FANTOO, an all-in-one social media experience connecting K-culture fans globally, today announced a strategic partnership with AISUL, a company specializing in artificial intelligence and the developer of the first digital female singer “Lusia” […]

OKYO Pharma (Nasdaq: OKYO) Announces Pricing of $4.0 Million Registered Direct Offering of Ordinary Shares

LONDON and NEW YORK, Sept. 14, 2023 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO) (“OKYO” or the “Company”), an ophthalmology-focused bio-pharmaceutical company which is developing OK-101 to treat dry eye disease (“DED”), today announced the pricing of a Company best efforts registered direct offering of 2,666,667 ordinary shares at an offering price of $1.50 per ordinary […]

Inspire Veterinary Partners, Inc. (NASDAQ:IVP) Announces Leadership Appointments Enhancing Operational and Financial Talent to Support Future Growth

Dr. Chuck Dunn, Joins Inspire as Director of Medical Operations; Kimberly King Joins Inspire as Director of Field Operations; and Debbe Bastian Joins Inspire as Finance Controller VIRGINIA BEACH, VA / ACCESSWIRE / September 13, 2023 / Inspire Veterinary Partners, Inc. (NASDAQ:IVP) (“Inspire” or the “Company”), an owner and provider of pet health care services throughout […]

Laser Photonics (NASDAQ: LASE) Introduces New CleanTech Robotic Cell Enclosure to Automate Laser Cleaning

ORLANDO, Fla., September 12, 2023–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE), a leading global industrial developer of CleanTech laser systems for laser cleaning and other material applications, today introduced its new CleanTech Robotic Cell Enclosure. “Our CleanTech Robotic Cell Enclosure is the first commercially available and easily programmable, AI-capable laser cleaning system in the United States,” […]

1847 (NYSE American:EFSH) Subsidiary, ICU Eyewear, Successfully Completes Refinancing and Upsizing of $15 Million Revolving Credit Facility

NEW YORK, NY / ACCESSWIRE / September 12, 2023 / 1847 Holdings LLC(“1847” or the “Company”) (NYSE American:EFSH), a unique holding company that combines the attributes of owning private, lower-middle market businesses with the liquidity and transparency of a publicly traded company, today announced that its subsidiaries, 1847 ICU Holdings Inc., its subsidiary, ICU Eyewear Holdings, […]

Longeveron (NASDAQ: LGVN) Reports 100% 5-Year Survival In Trial For Rare Pediatric Disease HLHS (Compared To 80% Survival In Historical Trials) To Market

MIAMI, FL –News Direct– LONGEVERON INC. By David Willey, Benzinga Advancements in healthcare and medicine have helped contribute to the reduction in child mortality rates, plummeting from 185 per 1,000 births a century ago to just 7 per 1,000 births in 2020. However, some serious pediatric conditions continue to pose a threat. One is hypoplastic left […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.